Biomedical subjects

Fabien Bévalot

Publications and source records attributed to Fabien Bévalot.

3 recordsLinked to original sources

PubMed2007

Fatal mephenesin intoxication.

This report describes a death related to the abuse of and intoxication by mephenesin. To the best of our knowledge, this is the first report case of lethal intoxication involving solely mephenesin and reporting mephenesin blood concentrations. The victim was a 48-year-old woman found unconscious at home. Resuscitation was unsuccessful. Toxicological analysis was performed on a blood sample collected during resuscitation. The results being negative, the body was exhumed for an autopsy, which revealed bronchial inhalation syndrome. Analysis in a second laboratory has revealed the presence of mephenesin in samples collected during autopsy. No other drug/toxin was found, and alcohol was negative. Reanalysis of the peripheral blood collected during resuscitation found a mephenesin concentration of 15.81 microg/mL (15-fold greater that the maximum concentration that would result from a single intake of a 500 mg formulation). The pathologist has concluded on a bronchial inhalation syndrome consecutive to a mephenesin overdose as the cause of death. The manner of this death is discussed in the light of the toxicological hair analysis and the medical past of the victim.

Bronchial Diseases↗

PubMed2006

Identification of 5-hydroxy-tryptamine (bufotenine) in takini (Brosimumacutifolium Huber subsp. acutifolium C.C. Berg, Moraceae), a shamanic potion used in the Guiana Plateau.

This paper is the first thorough analysis of takini, a hallucinogen used by the shamans of several peoples in Suriname, French Guiana, and the region east of the Para in Brazil. The drug is contained in the latex of the Brosimum acutifolium tree, and until now, its psychotropic properties appeared inconsistent with the more general medicinal uses of the tree in the surrounding region. Our chemical and botanical studies reveal that the active ingredient of takini is bufotenine; and that this compound is only contained in the subspecies Brosimum acutifolium Huber subsp. acutifolium C.C. Berg that is found in the same area of the eastern Guianas.

Bufotenin↗

PubMed2002

Bioequivalence evaluation of a fixed combination of chloroquine and proguanil in a capsule formulation versus a standard medication.

To assess the bioequivalence between a test capsule with a fixed combination of chloroquine (CAS 54-05-7) and proguanil (CAS 500-92-5), and chloroquine and proguanil administered as separate tablets, an open two-sequence, two-period cross-over randomized study was performed in twelve healthy volunteers who received a single oral dose of 100 mg chloroquine and 200 mg proguanil either in the form of one capsule or the reference tablets. Biological samples (plasma, whole blood and erythrocytes) were collected up to 43 days after drug administration. The parent drugs and their main metabolites were analyzed using high performance liquid chromatography assay. Bioequivalence was assessed for whole blood and plasma AUC and Cmax of chloroquine, proguanil, cycloguanil and 4-chlorophenylbiguanide. Bioequivalence in erythrocytes was also established except for Cmax of chloroquine. While the differences for Cmax of chloroquine in erythrocytes may be related to technical problems during the erythrocyte sampling procedure (contamination with leukocytes), bioequivalence can be concluded from the plasma concentration data. Therefore, the use of a single capsule instead of one chloroquine tablet and two proguanil tablets daily can be proposed in order to increase the prophylactic compliance without decreasing the prophylactic efficacy.

Adult↗